<DOC>
	<DOC>NCT00367978</DOC>
	<brief_summary>This study evaluated the efficacy and safety of amlodipine/benazepril compared with that of enalapril in the treatment of hypertension in African-American patients with type 2 diabetes.</brief_summary>
	<brief_title>Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Benazepril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>AfricanAmerican males and females current diagnosis of type 2 diabetes documented by medical history; mean sitting diastolic blood pressure of ≥ 90 and ≤ 110 mm Hg; HbA1C ≤ 9.5% having unilateral or bilateral renal artery stenosis; having clinically significant cardiac dysrhythmias; having a significant history of coronary artery disease within the past 6 months; having a history or diagnosis of congestive heart failure (CHF); having any clinically relevant cardiac valvular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Hypertension, diabetes, African-American, amlodipine/benazepril</keyword>
</DOC>